Insight With Beth Ruyak

Hosted By Beth Ruyak

Insight creates conversation to build community, exploring issues and events that connect people in our region. Insight covers breaking news and big ideas, music, arts & culture with responsible journalism, civil discussion and diverse voices.

Schedule

Monday – Thursday, 9 a.m. – 10 a.m.
on News Station

 We Get Support From:
Become a Supporter 
 We Get Support From:
Become a Supporter 

COVID-19 Drug ‘Remdesivir’ Concerns, Potential

Monday, May 11, 2020 | Sacramento, CA | Permalink
CDC via AP

This illustration provided by the Centers for Disease Control and Prevention (CDC) in January 2020 shows the 2019 Novel Coronavirus (2019-nCoV).

CDC via AP

Remdesivir is a drug in clinical trials showing promise in reducing the severity of COVID-19 in those infected. 

It was recently approved by the U.S. FDA, and the government has said it's distributing the promising coronavirus drug to the hardest-hit areas of the country. Eventually, all 50 states will get it. 

We take a closer look at Remdesivir and its prospects as a longterm solution to the coronavirus.  

Guests
  • UC Davis School of Veterinary Medicine Distinguished Professor Emeritus Dr. Niels Pedersen

Comments

Back to Top